Study on the best dose of esketamine in pediatric outpatient tongue frenulectomy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053451

Enrollment

Unknown

Registered

2021-11-21

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group A:esketamine 0.5mg/kg

Group B:esketamine 0.75mg/kg

Group C:esketamine 1mg/kg

Eligibility

Sex/Gender

Male

Age

1 Years to 10 Years

Inclusion criteria

Inclusion criteria: Children with elective tongue frenulectomy in outpatient clinic; ASA grade I-II; first surgical treatment.

Exclusion criteria

Exclusion criteria: 1. Complicated with severe oral and maxillofacial diseases; severe heart, liver and renal insufficiency; 2. Those with clear mental and nervous system diseases; those with retarded growth and intellectual development; those with contraindications to esketamine.

Design outcomes

Primary

Measure	Time frame
Adverse event rate;	—

Secondary

Measure	Time frame
Dosage of anesthetic drugs ;Intraoperative vital signs;	—

Countries

China

Contacts

Public ContactJia Yingping

Henan Children's Hospital

zlytmz@163.com+86 13526562868

Outcome results